COURSE OVERVIEW
This evidence-based course is designed to introduce family physicians, specialist physicians, pharmacists and nurse practitioners to new medications, new indications for older products and new guidelines for treatment. Current therapeutics controversies are examined and drug and non-drug therapeutic approaches for selected clinical conditions are presented.
COURSE OBJECTIVES
-
identify new medications and new indications for “old” products
-
examine current therapeutic controversies
-
compare drug and non-drug approaches for selected clinical conditions
-
discuss the types of evidence used to support the prescribing of one drug instead of another in the same class of drugs
WHO SHOULD ATTEND
Family Physicians, Pharmacists, Specialist Physicians, Nurse Practitioners, Other healthcare professionals
CREDITS
Mainpro+ Group Learning – 13.5 credits
MOC Section 1 – 13.5 credits
Application for accreditation has been made to the
Canadian Council on Continuing Education in Pharmacy.
Program Number Pharmacists: 1180-2018-2310-C-P
Program Number Technicians: 1180-2018-2338-C-T
MORE INFORMATION
To register or to find out more information visit the University of Calgary Continuing Medical Education & Professional Development website.